Highlights and Announcements

The National Institutes of Health (NIH) has selected 10 recipients of the NIH Institutional Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) in Biomedical and Behavioral Research Prize. Among the awardees—each receiving $100,000—is the University of Puerto Rico-Rio Piedras (UPR-RP) in recognition of their Neuroscience Research Opportunities to Increase Diversity (NeuroID) program.

Team science expands our ability to pursue some of the most challenging problems in neuroscience in a comprehensive, multidisciplinary, and mechanistic manner. The National Institute of Neurological Disorders and Stroke (NINDS) announces the first round of awards for the new NINDS Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) program.

ReveraGen BioPharma, a company supported by a small business grant from the National Institute of Neurological Disorders and Stroke (NINDS), has developed a new drug for Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease.

The National Institutes of Health (NIH) is committed to advancing research on amyotrophic lateral sclerosis (ALS). There is currently no cure for ALS although FDA-approved drugs are available to treat ALS symptoms or slow ALS progression.

In the human brain, 86 billion neurons form more than 100 trillion connections with other neurons at junctions called synapses. Scientists are now working on an ambitious effort to develop technologies to map these connections across the brain, from mice to humans.

Today, the National Institute of Neurological Disorders and Stroke (NINDS) announced the selection of neuroscientist Jeffrey S. Diamond, Ph.D., as Scientific Director.

Dr. Michael Oshinsky, Director of the NINDS Office of Preclinical Pain Research, is the featured guest on the July 27 episode of the Spotlight on Migraine podcast, “Understanding and Managing Migraine in Kids and Teens.”

NINDS is mourning the death of Dr. Ralph Sacco, renowned stroke neurologist who enriched NINDS as a grantee, mentor, and member of the NINDS Advisory Council. Dr. Sacco passed away on January 17, 2023, due to a brain tumor. He was 65.

Today NIH Acting Director Dr. Lawrence Tabak announced the selection of Nina F. Schor, M.D., Ph.D., as the new NIH Acting Deputy Director for Intramural Research (DDIR). She will replace Michael M. Gottesman, M.D., who served as NIH DDIR for the past 29 years.